Establishing a sustainable and effective payerstrategy with analytics
Transforming market access by addressing a wide range of key business questions
With the changing landscape of the pharma and life sciences industry, it has become imperative for pharmaceutical companies to work in tandem with payers to drive more value to patients.
Pharmaceutical companies need effective strategies to get the best reimbursements for their drugs, making it affordable for payers so that patients can access effective therapies easily.
Payer analytics at Axtria
Addressing a wide range of key businessquestions related to Payer analytics
Pricing & Contracting
Market Access
Health Systems
Account Managers
Payer Insights & Analytics
%20(1).png?width=104&height=102&name=Payer-analytics-icon1%20(1)%20(1).png)
.png?width=104&height=103&name=Payer-analytics-icon1_active%20(1).png)
%20(1).png?width=104&height=108&name=Payer-analytics-icon2%20(1)%20(1).png)
.png?width=104&height=102&name=Payer-analytics-icon2_active%20(1).png)
%20(1).png?width=104&height=104&name=Payer-analytics-icon3%20(1)%20(1).png)
.png?width=104&height=102&name=Payer-analytics-icon3_active%20(1).png)
%20(1).png?width=104&height=105&name=Payer-analytics-icon4%20(1)%20(1).png)
.png?width=104&height=104&name=Payer-analytics-icon4_active%20(1).png)
%20(1).png?width=104&height=105&name=Payer-analytics-icon5%20(2)%20(1).png)
.png?width=104&height=105&name=Payer-analytics-icon5_active%20(1).png)
%20(1).png?width=104&height=105&name=Payer-analytics-icon6%20(2)%20(1).png)
.png?width=104&height=105&name=Payer-analytics-icon6_active%20(1).png)
- Payer Utilization Management
- Define Payer Control
- Payer performance
- Optimum Copay level
- Switch classification
- Copay curve analysis
- KAM Effectiveness tools
- Patient-level simulation
- Graphical outcome measures
- Contracting lever analysis
- AI-enabled Contracting decisions
- Spillover analysis
- Patient volume, adherence
- Specialty Pharmacy Effectiveness
- ML-based Patient adherence
- Data-driven payer segmentation
- Qualitative research with payer profiling